Decibel Cannabis Company Inc. (DB.V)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 40.96 Million CAD | 0.25% |
| 2022 | 48.39 Million CAD | -3.02% |
| 2021 | 49.9 Million CAD | 15.53% |
| 2020 | 43.19 Million CAD | 6.52% |
| 2019 | 40.54 Million CAD | 887.03% |
| 2018 | 4.1 Million CAD | 14562.0% |
| 2017 | 28.01 Thousand CAD | 116.91% |
| 2016 | 12.91 Thousand CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | 5474.00 CAD | -95.31% |
| 2013 | 116.61 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | -100.0% |
| 2008 | 627.83 Thousand CAD | 8.43% |
| 2007 | 579.01 Thousand CAD | -57.35% |
| 2006 | 1.35 Million CAD | -9.36% |
| 2005 | 1.49 Million CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| 2000 | - CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| 1998 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 46.25 Million CAD | -2.36% |
| 2024 Q1 | 47.37 Million CAD | -2.35% |
| 2023 Q3 | 47.37 Million CAD | -2.01% |
| 2023 FY | 48.51 Million CAD | 0.25% |
| 2023 Q2 | 48.34 Million CAD | -1.91% |
| 2023 Q1 | 49.28 Million CAD | 1.83% |
| 2023 Q4 | 48.51 Million CAD | 2.41% |
| 2022 Q4 | 48.39 Million CAD | -0.65% |
| 2022 Q1 | 49.52 Million CAD | -0.75% |
| 2022 Q2 | 48.78 Million CAD | -1.5% |
| 2022 FY | 48.39 Million CAD | -3.02% |
| 2022 Q3 | 48.71 Million CAD | -0.14% |
| 2021 Q2 | 50.94 Million CAD | 13.54% |
| 2021 Q1 | 44.86 Million CAD | 3.88% |
| 2021 FY | 49.9 Million CAD | 15.53% |
| 2021 Q4 | 49.9 Million CAD | -5.16% |
| 2021 Q3 | 52.61 Million CAD | 3.28% |
| 2020 Q1 | 41.18 Million CAD | 1.58% |
| 2020 Q4 | 43.19 Million CAD | 3.67% |
| 2020 Q3 | 41.66 Million CAD | -1.62% |
| 2020 FY | 43.19 Million CAD | 6.52% |
| 2020 Q2 | 42.34 Million CAD | 2.82% |
| 2019 Q2 | 18.37 Million CAD | 306.86% |
| 2019 Q1 | 4.51 Million CAD | 0.0% |
| 2019 FY | 40.54 Million CAD | 887.03% |
| 2019 Q4 | 40.54 Million CAD | 93.8% |
| 2019 Q3 | 20.92 Million CAD | 13.87% |
| 2018 Q2 | - CAD | -100.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q1 | 39.17 Thousand CAD | 0.0% |
| 2018 FY | 4.1 Million CAD | 14562.0% |
| 2017 Q2 | 28.01 Thousand CAD | 7.82% |
| 2017 Q4 | 39.17 Thousand CAD | 30.85% |
| 2017 FY | 28.01 Thousand CAD | 116.91% |
| 2017 Q1 | 25.98 Thousand CAD | 5.32% |
| 2017 Q3 | 29.94 Thousand CAD | 6.86% |
| 2016 Q4 | 24.67 Thousand CAD | 14.85% |
| 2016 FY | 12.91 Thousand CAD | 0.0% |
| 2016 Q3 | 21.48 Thousand CAD | 66.31% |
| 2016 Q2 | 12.91 Thousand CAD | 0.0% |
| 2016 Q1 | 12.91 Thousand CAD | 30.25% |
| 2015 Q3 | 8605.00 CAD | 0.0% |
| 2015 Q4 | 9917.00 CAD | 15.25% |
| 2015 Q2 | - CAD | -100.0% |
| 2015 Q1 | 2080.00 CAD | -70.79% |
| 2015 FY | - CAD | -100.0% |
| 2014 Q3 | 5741.00 CAD | 4.88% |
| 2014 Q2 | 5474.00 CAD | -94.84% |
| 2014 FY | 5474.00 CAD | -95.31% |
| 2014 Q1 | 106.13 Thousand CAD | 86.53% |
| 2014 Q4 | 7121.00 CAD | 24.04% |
| 2013 Q2 | 116.61 Thousand CAD | 2.9% |
| 2013 Q1 | 113.32 Thousand CAD | 21.94% |
| 2013 Q3 | 15.44 Thousand CAD | -86.76% |
| 2013 Q4 | 56.89 Thousand CAD | 268.49% |
| 2013 FY | 116.61 Thousand CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | 92.93 Thousand CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | -100.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 Q2 | 627.83 Thousand CAD | 2.11% |
| 2008 Q4 | - CAD | -100.0% |
| 2008 Q3 | 521.75 Thousand CAD | -16.9% |
| 2008 Q1 | 614.85 Thousand CAD | 6.89% |
| 2008 FY | 627.83 Thousand CAD | 8.43% |
| 2007 Q1 | 580.82 Thousand CAD | 2.11% |
| 2007 Q4 | 575.24 Thousand CAD | 0.91% |
| 2007 Q3 | 570.04 Thousand CAD | -1.55% |
| 2007 Q2 | 579.01 Thousand CAD | -0.31% |
| 2007 FY | 579.01 Thousand CAD | -57.35% |
| 2006 Q2 | 1.35 Million CAD | -4.58% |
| 2006 Q3 | 1.37 Million CAD | 1.44% |
| 2006 Q1 | 1.42 Million CAD | -0.92% |
| 2006 Q4 | 568.83 Thousand CAD | -58.7% |
| 2006 FY | 1.35 Million CAD | -9.36% |
| 2005 Q3 | 1.44 Million CAD | -3.73% |
| 2005 Q2 | 1.49 Million CAD | -5.76% |
| 2005 FY | 1.49 Million CAD | 0.0% |
| 2005 Q4 | 1.43 Million CAD | -0.41% |
| 2005 Q1 | 1.58 Million CAD | 4.06% |
| 2004 Q1 | 64.72 Thousand CAD | -46.07% |
| 2004 Q2 | - CAD | -100.0% |
| 2004 Q4 | 1.52 Million CAD | 6045.92% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q3 | 24.85 Thousand CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q4 | 120 Thousand CAD | 0.0% |
| 2003 Q3 | 120 Thousand CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2001 Q1 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 Q2 | - CAD | 0.0% |
| 2000 Q2 | - CAD | 0.0% |
| 2000 FY | - CAD | 0.0% |
| 2000 Q3 | - CAD | 0.0% |
| 1999 Q3 | 114.7 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| 1998 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5.06 Million CAD | -708.962% |
| CanadaBis Capital Inc. | 7.3 Million CAD | -460.436% |
| Delivra Health Brands Inc. | 2.02 Million CAD | -1920.918% |
| Entourage Health Corp. | 161.58 Million CAD | 74.648% |
| Lifeist Wellness Inc. | 1.26 Million CAD | -3135.662% |
| Cannara Biotech Inc. | 45.78 Million CAD | 10.526% |
| Medicure Inc. | 544 Thousand CAD | -7430.147% |
| PharmaCielo Ltd. | 18.3 Million CAD | -123.741% |
| Rubicon Organics Inc. | 10.25 Million CAD | -299.276% |
| BioSyent Inc. | 1.22 Million CAD | -3254.831% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -102310.0% |